Progesterone Treatment in Female Smokers - 12
NCT00000295 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2017-01-12
Summary
The purpose of this study is to investigate progesterone effects in female smokers
Conditions
- Tobacco Use Disorder
Interventions
- DRUG
-
Micronized Progesterone
Sponsors & Collaborators
- collaborator OTHER
-
National Institute on Drug Abuse (NIDA)
lead NIH
Principal Investigators
-
Dorothy Hatsukami, Ph.D. · University of Minnesota
Study Design
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 21 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1999-04-30
- Completion
- 2001-12-31
Countries
- United States
Study Locations
More Related Trials
-
Buccal Estrogen in Toothpaste Study: Systemic Absorption of Estradiol When Administered Mixed With Toothpaste in Postmenopausal or Surgically Menopausal Women
NCT00029757 ·Status: COMPLETED ·Phase: NA
-
Progestagen Type in Postmenopausal Hormone Therapy and Blood Gene Expression Profile
NCT01123538 ·Status: UNKNOWN ·Phase: PHASE4
-
Hormone Replacement Therapy and Insulin Action: A Double-Blind, Parallel, Placebo-Controlled Hormone Intervention Study in Postmenopausal Women
NCT00005769 ·Status: UNKNOWN ·Phase: PHASE2
-
Estrogen, HDL, and Coronary Heart Disease in Women
NCT00083824 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Vasomotor Symptoms (VMS) Progesterone Study: Vasomotor Symptoms and Endothelial Function - Trial of Oral Micronized Progesterone
NCT00152438 ·Status: UNKNOWN ·Phase: PHASE2
-
Examining the Impact of Phytoestrogens Supplementation on the Gene Expression, and Premenstrual Syndrome in Primenopausal Women
NCT07310485 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
A Study of the Effect of Estrogen on Estrogen Receptor Biomarkers in Healthy Postmenopausal Women (0000-094)(COMPLETED)
NCT00799708 ·Status: COMPLETED ·Phase: PHASE1
-
Hormone Replacement and Neural Cardiovascular Control in Postmenopausal Women
NCT01633814 ·Status: TERMINATED ·Phase: NA
-
Evaluating the Roles of Estrogen and Progesterone in Heart Metabolism
NCT00565916 ·Status: TERMINATED ·Phase: NA
-
Unique Effects of Perimenstrual Estradiol or Progesterone Supplementation on Perimenstrual Suicidality
NCT03498313 ·Status: COMPLETED ·Phase: PHASE4
-
Estrogen Modulation of Mood and Cognition Following Monoaminergic Depletion in Post-Menopausal Women
NCT00005768 ·Status: UNKNOWN ·Phase: PHASE2
-
Bioidentical 'Natural' Hormone Evaluation in Early Menopause
NCT00302731 ·Status: TERMINATED ·Phase: PHASE2
-
The Effect of Grape Seed Extract on Estrogen Levels of Postmenopausal Women
NCT00566553 ·Status: COMPLETED ·Phase: NA
-
Use of the Synthetic Hormone CDB-2914 in Treating Symptoms of Menopause
NCT00009659 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Hormone Replacement Therapy on Cardiovascular Risk and Body Composition Parameters
NCT04453332 ·Status: UNKNOWN ·Phase: NA
-
The Effects of Estrogen Withdrawal on Mood Symptoms in Women
NCT00060736 ·Status: COMPLETED
-
Efficacy Study of Progesterone Tablet in Post-menopausal Women
NCT02841137 ·Status: COMPLETED ·Phase: PHASE2
-
Timing Estrogen After MenoPaUSe
NCT01605071 ·Status: COMPLETED ·Phase: NA
-
Effect of a Natural Health Product on Urinary Estrogen Metabolites
NCT01089049 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Postprandial Lipidemia After a Meal With Different Types of Fat, Estrogen Treatment, Age and Gender in Healthy Subjects
NCT02383823 ·Status: WITHDRAWN ·Phase: NA
-
Estrogen Use in Protection From Cognitive Decline
NCT00097058 ·Status: COMPLETED
-
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
NCT01942668 ·Status: COMPLETED ·Phase: PHASE3
-
Alzheimer's Disease Prevention Trial
NCT00000176 ·Status: COMPLETED ·Phase: PHASE3
-
Phytoestrogens and Memory Decline in Menopause
NCT00051402 ·Status: COMPLETED ·Phase: PHASE2
-
Progesterone and Resting Energy Expenditure
NCT04140968 ·Status: TERMINATED ·Phase: PHASE4